7451 - 7500 of 7730 Results
Title
Year
-
RESTRICTEDTitle: SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 67Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.279Best OA location URL: https://europepmc.org/articles/pmc3010848?pdf=renderCitation Count: 149
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
- CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease2010RESTRICTEDTitle: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 1Start Page: 23End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5Best OA location URL: https://europepmc.org/articles/pmc3090073?pdf=renderCitation Count: 13
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010RESTRICTEDTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
-
RESTRICTEDTitle: PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 52Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3001059Best OA location URL: https://europepmc.org/articles/pmc3129986?pdf=renderCitation Count: 709
-
RESTRICTEDTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 143
-
RESTRICTEDTitle: Biomarkers in Parkinson’s disease: a funder’s perspectiveJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 723End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.89Citation Count: 15
- LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease2010RESTRICTEDTitle: LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 1Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.04.002Best OA location URL: https://europepmc.org/articles/pmc2926296?pdf=renderCitation Count: 126
-
RESTRICTEDTitle: Toxicological and pathophysiological roles of reactive oxygen and nitrogen speciesJournal Name: ToxicologyPublisher: Elsevier BVVol: 276Issue #: 2Start Page: 85End Page: 94Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tox.2010.07.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237863Citation Count: 181
-
RESTRICTEDTitle: Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 701End Page: 712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.94Best OA location URL: https://europepmc.org/articles/pmc3049925?pdf=renderCitation Count: 119
- Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis2010RESTRICTEDTitle: Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 82Issue #: 5Start Page: 564End Page: 568Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp.2010.222042Best OA location URL: https://europepmc.org/articles/pmc4646086?pdf=renderCitation Count: 89
-
RESTRICTEDTitle: Estimation of Particulate Mass and Manganese Exposure Levels among WeldersJournal Name: The Annals of Occupational HygienePublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/annhyg/meq069Best OA location URL: https://academic.oup.com/annweh/article-pdf/55/1/113/11209915/meq069.pdfCitation Count: 44
-
RESTRICTEDTitle: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairmentJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 120Issue #: 6Start Page: 827End Page: 828Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=renderCitation Count: 77
-
RESTRICTEDTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Best OA location URL: https://europepmc.org/articles/pmc2939261?pdf=renderCitation Count: 39
- Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations2010RESTRICTEDTitle: Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutationsJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1791End Page: 1800Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23221Best OA location URL: https://europepmc.org/articles/pmc6005705?pdf=renderCitation Count: 228
-
RESTRICTEDTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Best OA location URL: https://europepmc.org/articles/pmc2939165?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://europepmc.org/articles/pmc2978754?pdf=renderCitation Count: 163
-
RESTRICTEDTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://europepmc.org/articles/pmc2978749?pdf=renderCitation Count: 62
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys2010RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Citation Count: 143
- Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia2010RESTRICTEDTitle: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementiaJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 225Issue #: 1Start Page: 210End Page: 218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.06.017Best OA location URL: https://europepmc.org/articles/pmc2922478?pdf=renderCitation Count: 170
- Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)2010RESTRICTEDTitle: Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 20Issue #: 17Start Page: 5175End Page: 5178Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2010.07.007Best OA location URL: https://europepmc.org/articles/pmc2922490?pdf=renderCitation Count: 26
-
RESTRICTEDTitle: Systemic Weakness After Therapeutic Injections of Botulinum Toxin AJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 33Issue #: 5Start Page: 243End Page: 247Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0b013e3181f5329eBest OA location URL: https://europepmc.org/articles/pmc3563356?pdf=renderCitation Count: 79
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization2010RESTRICTEDTitle: 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localizationJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 430Issue #: 3Start Page: 393End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1042/bj20100483Best OA location URL: https://portlandpress.com/biochemj/article-pdf/430/3/393/878058/bj4300393.pdfCitation Count: 354
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization2010RESTRICTEDTitle: Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localizationJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 430Issue #: 3Start Page: 405End Page: 413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20100784Best OA location URL: https://portlandpress.com/biochemj/article-pdf/430/3/405/664434/bj4300405.pdfCitation Count: 352
-
RESTRICTEDTitle: Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 998End Page: 1000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nm.2199Best OA location URL: https://europepmc.org/articles/pmc2935926?pdf=renderCitation Count: 337
-
RESTRICTEDTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://europepmc.org/articles/pmc2978804?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 48
-
RESTRICTEDTitle: Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 62Issue #: 3Start Page: 405End Page: 496Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.109.002451Best OA location URL: https://europepmc.org/articles/pmc2964903?pdf=renderCitation Count: 2923
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease2010RESTRICTEDTitle: Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 42Issue #: 9Start Page: 781End Page: 785Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ng.642Best OA location URL: https://europepmc.org/articles/pmc2930111?pdf=renderCitation Count: 698
- Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)2010RESTRICTEDTitle: Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)Journal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 11Start Page: 1530End Page: 1537Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23151Best OA location URL: https://europepmc.org/articles/pmc4775095?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: Postmortem interval effect on RNA and gene expression in human brain tissueJournal Name: Cell and Tissue BankingPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 311End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10561-010-9210-8Best OA location URL: https://europepmc.org/articles/pmc3343031?pdf=renderCitation Count: 125
- Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons2010RESTRICTEDTitle: Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neuronsJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 282End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/cdd.2010.92Best OA location URL: https://www.nature.com/articles/cdd201092.pdfCitation Count: 158
-
RESTRICTEDTitle: Genetic variability at the PARK16 locusJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 12Start Page: 1356End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ejhg.2010.125Best OA location URL: https://www.nature.com/articles/ejhg2010125.pdfCitation Count: 85
- Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases2010RESTRICTEDTitle: Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 114Issue #: 5Start Page: 1261End Page: 1276Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06834.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2010.06834.xCitation Count: 30
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010RESTRICTEDTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 367
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors2010RESTRICTEDTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 69
-
RESTRICTEDTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://europepmc.org/articles/pmc2943649?pdf=renderCitation Count: 182
- Low‐dose bafilomycin attenuates neuronal cell death associated with autophagy‐lysosome pathway dysfunction2010RESTRICTEDTitle: Low‐dose bafilomycin attenuates neuronal cell death associated with autophagy‐lysosome pathway dysfunctionJournal Name: Journal of NeurochemistryPublisher: WileyVol: 114Issue #: 4Start Page: 1193End Page: 1204Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06838.xBest OA location URL: https://europepmc.org/articles/pmc2910188?pdf=renderCitation Count: 46
-
RESTRICTEDTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://europepmc.org/articles/pmc2889226?pdf=renderCitation Count: 14
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N-Methyl-d-aspartate Receptor Antagonists2010RESTRICTEDTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jm100027pBest OA location URL: https://europepmc.org/articles/pmc2920070?pdf=renderCitation Count: 84
-
RESTRICTEDTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
- Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa2010RESTRICTEDTitle: Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North AfricaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 477Issue #: 2Start Page: 57End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2009.11.066Best OA location URL: https://europepmc.org/articles/pmc2970621?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Risk of sleep-disordered breathing in Parkinson's diseaseJournal Name: Sleep and BreathingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 3Start Page: 471End Page: 478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11325-010-0362-3Best OA location URL: https://europepmc.org/articles/pmc2978748?pdf=renderCitation Count: 41
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice2010RESTRICTEDTitle: Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged miceJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 107Issue #: 21Start Page: 9879End Page: 9884Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1004676107Best OA location URL: https://europepmc.org/articles/pmc2906862?pdf=renderCitation Count: 460
-
RESTRICTEDTitle: Prevention strategies for herpes zoster and post-herpetic neuralgiaJournal Name: Journal of Clinical VirologyPublisher: Elsevier BVVol: 48Issue #:Start Page: S14End Page: S19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1386-6532(10)70004-4Best OA location URL: https://europepmc.org/articles/pmc5391038?pdf=renderCitation Count: 32
- Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease2010RESTRICTEDTitle: Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3000664Best OA location URL: https://europepmc.org/articles/pmc2933751?pdf=renderCitation Count: 130
-
RESTRICTEDTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: https://europepmc.org/articles/pmc2935627?pdf=renderCitation Count: 113
-
RESTRICTEDTitle: Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmJournal Name: Protein Engineering, Design and SelectionPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/protein/gzq022Best OA location URL: https://academic.oup.com/peds/article-pdf/23/6/489/17494272/gzq022.pdfCitation Count: 55
-
RESTRICTEDTitle: Parkinson’s PsychosisJournal Name: Current Treatment Options in NeurologyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 3Start Page: 200End Page: 211Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11940-010-0072-yBest OA location URL: https://europepmc.org/articles/pmc3045857?pdf=renderCitation Count: 23
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders2010RESTRICTEDTitle: Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disordersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 119Issue #: 6Start Page: 689End Page: 702Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0664-3Best OA location URL: https://europepmc.org/articles/pmc2866090?pdf=renderCitation Count: 773